Spots Global Cancer Trial Database for in vivo drug sensitivity
Every month we try and update this database with for in vivo drug sensitivity cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies | NCT04541108 | Solid Tumor | Rilvegostomig Volrustomig Sabestomig Pembrolizumab | 18 Years - | Presage Biosciences | |
Intratumoral Microdosing of TAK-981 in Head and Neck Cancer | NCT04065555 | Head and Neck C... | TAK-981 Cetuximab Avelumab TAK-981 + Cetux... TAK-981 + Avelu... | 18 Years - | Presage Biosciences | |
Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies | NCT04541108 | Solid Tumor | Rilvegostomig Volrustomig Sabestomig Pembrolizumab | 18 Years - | Presage Biosciences | |
Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies | NCT04541108 | Solid Tumor | Rilvegostomig Volrustomig Sabestomig Pembrolizumab | 18 Years - | Presage Biosciences | |
CIVO Intratumoural Microdosing of Anti-Cancer Therapies in Australia | NCT04891718 | Solid Tumour | MVC-101 Nivolumab MVC-101 + Nivol... | 18 Years - | Presage Biosciences | |
PBI-MST-01(NCT04541108) Substudy TAK-02: Intratumoral Microdosing of TAK-676 in HNSCC | NCT06062602 | Head and Neck S... | TAK-676 Carboplatin 5-FU Paclitaxel TAK-676 + Carbo... Carboplatin + P... Carboplatin + 5... TAK-676 + Carbo... TAK-676 + Carbo... | 18 Years - | Presage Biosciences | |
Precise Local Injection of Anti-cancer Drugs Using Presage's CIVO Device in Soft Tissue Sarcoma | NCT03056599 | Soft Tissue Sar... | Multiple drug m... CIVO device | 18 Years - | Presage Biosciences | |
Feasibility of Assessing Lymphoma Response to Precise Local Injection of Candidate Chemotherapy Agents | NCT01831505 | Lymphoma | Multiple drug m... | 18 Years - | Presage Biosciences | |
Intratumoral Microdosing of TAK-981 in Head and Neck Cancer | NCT04065555 | Head and Neck C... | TAK-981 Cetuximab Avelumab TAK-981 + Cetux... TAK-981 + Avelu... | 18 Years - | Presage Biosciences |